Img header logo

GRI Standards Content Index

ONO PHARMACEUTICAL CO.,LTD., ONO PHARMACEUTICAL CO.,LTD., system

GRI Standards Content Index

Our website refers to the Global Reporting Initiative (GRI) Standards.The descriptions are shown in this comparative table.

General Disclosures
Disclosure Number Description References/Response
1. Organizational profile
102-1 Name of the organization
  1. Company Profile
102-2 Activities, brands, products, and services
  1. Main Products
102-3 Location of headquarters
  1. Business Locations
102-4 Location of operations
  1. Business Locations
102-5 Ownership and legal form
  1. Company Profile
102-6 Markets served
  1. Global Business
102-7 Scale of the organization
  1. Company Profile
  2. Business Locations
  3. Financial Highlights
  4. Main Products
102-12 External initiatives
  1. Participation in the United Nations Global Compact
  2. Environmental Initiatives
    （Science Based Targets initiative,Task Force on Climate-related Financial Disclosures,Renewable Energy 100%,etc.）
102-13 Membership of associations The Federation of Pharmaceutical Manufacturers’ Associations of JAPAN,Japan Pharmaceutical Manufacturers Association,KEIDANREN (Japan Business Federation),Kansai Pharmaceutical Industries Association,etc.
2. Strategy
102-14 Statement from senior decision-maker
  1. Top Message
102-15 Key impacts, risks, and opportunities
  1. ONO's Approach to CSR
  2. Global Environment Policy/Environment Challenging Ono Vision（ECO VISION 2050）
3. Ethics and integrity
102-16 Values, principles, standards, and norms of behavior
  1. Mission Statement
102-17 Mechanisms for advice and concerns about ethics
  1. Compliance
4. Governance
102-18 Governance structure
  1. Corporate Governance
102-19 Delegating authority
  1. CSR Promotion Structure
  2. Promotion of Environmental Management
102-20 Executive-level responsibility for economic, environmental, and social topics
  1. CSR Promotion Structure
102-22 Composition of the highest governance body and its committees
  1. Corporate Governance Report
102-23 Chair of the highest governance body
  1. Corporate Governance Report
102-24 Nominating and selecting the highest governance body
  1. Corporate Governance Report
102-25 Conflicts of interest
  1. Corporate Governance Report
102-28 Evaluating the highest governance body’s performance
  1. Corporate Governance Report
102-30 Effectiveness of risk management processes
  1. Corporate Governance Structure
102-31 Review of economic, environmental, and social topics
  1. ONO's Approach to CSR
102-32 Highest governance body’s role in sustainability reporting
  1. ONO's Approach to CSR
  2. CSR Promotion Structure
102-33 Communicating critical concerns
  1. Corporate Governance Structure
102-35 Remuneration policies
  1. Corporate Governance Report
102-36 Process for determining remuneration
  1. Corporate Governance Report
102-37 Stakeholders’ involvement in remuneration
  1. Corporate Governance Report
5. Stakeholder engagement
102-40 List of stakeholder groups
  1. Stakeholder Engagement
102-41 Collective bargaining agreements
  1. Social Data
102-43 Approach to stakeholder engagement
  1. Stakeholder Engagement
6. Reporting practice
102-46 Defining report content and topic Boundaries
  1. ONO's Approach to CSR
102-47 List of material topics
  1. ONO's Approach to CSR
102-49 Changes in reporting
  1. ONO's Approach to CSR
102-50 Reporting period
  1. CSR Report 2021 (P.2)：FY2021 (from April 2020 to March 2021)
  2. Corporate Report 2021 (P.4)：FY2020 (from April 1, 2020 to March 31, 2021)
102-51 Date of most recent report
  1. CSR Report 2021 (P.2)：October 2021
  2. Corporate Report 2021 (P.4)：September 2021
102-52 Reporting cycle
  1. WEB:Update as needed
  2. CSR Report, Corporate Report :Annual
102-53 Contact point for questions regarding the report
  1. Contact
102-55 GRI content index
  1. GRI Standards Comparative Table
102-56 External assurance
  1. Independent Practitioner's Assurance
GRI 103: Management Approach 2016
103-1 Explanation of the material topic and its Boundary
  1. ONO's Approach to CSR
  2. Risk Management
  3. Global Environment Policy/Environment Challenging Ono Vision（ECO VISION 2050）
103-2 The management approach and its components
  1. ONO's Approach to CSR
  2. Risk Management
  3. Global Environment Policy/Environment Challenging Ono Vision（ECO VISION 2050）
103-3 Evaluation of the management approach
  1. Risk Management
  2. Environmental Management
Economic topics
Disclosure Number Description Reference/Response
GRI 201: Economic Performance 2016
201-1 Direct economic value generated and distributed
  1. Financial Highlights
  2. Social Contribution Activities
201-2 Financial implications and other risks and opportunities due to climate change
  1. Information Disclosure Based on the TCFD Recommendation
  2. Risk Management
GRI 205: Anti-corruption 2016
205-3 Confirmed incidents of corruption and actions taken
  1. Governance Data
GRI 207: Tax 2019
207-1 Approach to tax
  1. Ono Pharmaceutical Global Tax Policy
207-2 Tax governance, control, and risk management
  1. Compliance Promotion Initiatives
207-3 Stakeholder engagement and management of concerns related to tax
  1. Ono Pharmaceutical Global Tax Policy
207-4 Country-by-country reporting
  1. Tax Reporting by Country or Region
Environmental topics
Disclosure Number Description Reference/Response
GRI 302: Energy 2016
302-1 Energy consumption within the organization
  1. Environmental Data
  2. Towards a Decarbonized Society
302-4 Reduction of energy consumption
  1. Towards a Decarbonized Society
GRI 303: Water and Effluents 2018
303-1 Interactions with water as a shared resource
  1. Toward Creating a Water Recycling-oriented Society
303-2 Management of water discharge-related impacts
  1. Biodiversity Conservation
303-3 Water withdrawal
  1. Toward Creating a Water Recycling-oriented Society
303-4 Water discharge
  1. Toward Creating a Water Recycling-oriented Society
303-5 Water consumption Water consumption for our company can be calculated as follows: Amount of water intake - Amount of wastewater = Amount of water consumption.
GRI 304: Biodiversity 2016
304-1 Operational sites owned, leased, managed in, or adjacent to, protected areas and areas of high biodiversity value outside protected areas
  1. Business Locations
  2. R＆D
  3. Manufacturing
  4. Marketing
  5. Safety and Quality Assurance
304-2 Significant impacts of activities, products, and services on biodiversity
  1. Biodiversity Conservation
304-3 Habitats protected or restored
  1. Biodiversity Conservation
GRI 305: Emissions 2016
305-1 Direct (Scope 1) GHG emissions
  1. Environmental Data
  2. Targets (Medium- to Long-term Targets and Fiscal Year Targets) and Results
305-2 Energy indirect (Scope 2) GHG emissions
  1. Environmental Data
  2. Targets (Medium- to Long-term Targets and Fiscal Year Targets) and Results
305-3 Other indirect (Scope 3) GHG emissions
  1. Environmental Data
  2. GHG Emissions in the Value Chain (Scope 3)
305-5 Reduction of GHG emissions
  1. Towards a Decarbonized Society
305-7 Nitrogen oxides (NOX), sulfur oxides (SOX), and other significant air emissions
  1. Environmental Data
  2. Reduction of Environmental Risks
GRI 306: Effluents and Waste 2016
306-2 Waste by type and disposal method
  1. Toward Realization of a Resource Recycling Society
306-3 Significant spills
  1. Environmental Data
  2. Toward Realization of a Resource Recycling Society
306-4 Transport of hazardous waste
  1. Environmental Data
  2. Toward Realization of a Resource Recycling Society
306-5 Water bodies affected by water discharges and/or runoff
  1. Environmental Data
  2. Progress Towards a Water Recycling Society
GRI 307: Environmental　Compliance 2016
307-1 Non-compliance with environmental laws and regulations
  1. Environmental Data
Social topics
Disclosure Number Description Reference/Response
GRI 401: Employment 2016
401-2 Benefits provided to full-time employees that are not provided to temporary or part-time employees
  1. Promoting the Creation of an Employee-friendly Working Environment
GRI 403: Occupational Health and Safety 2018
403-1 Occupational health and safety management system
  1. Promoting the Creation of an Employee-friendly Working Environment
403-3 Occupational health services
  1. Promoting the Creation of an Employee-friendly Working Environment
403-6 Promotion of worker health
  1. Organizational Structure to Promote Health Management
403-9 Work-related injuries
  1. Social Data
  2. Promoting the Creation of an Employee-friendly Working Environment
403-10 Work-related ill health
  1. Social Data
  2. Promoting the Creation of an Employee-friendly Working Environment
GRI 404: Training and Education 2016
404-2 Programs for upgrading employee skills and transition assistance programs
  1. Human Resource Development
GRI 405: Diversity and Equal Opportunity 2016
405-1 Diversity of governance bodies and employees
  1. Social Data
  2. Governance Data
  3. Promotion of Diversity and Inclusion
GRI 406: Non-discrimination 2016
406-1 Incidents of discrimination and corrective actions taken
  1. Governance Data
GRI 412: Human Rights Assessment 2016
412-2 Employee training on human rights policies or procedures
  1. Governance Data
  2. Compliance Promotion Initiatives
GRI 417: Marketing and Labeling 2016
417-1 Requirements for product and service information and labeling
  1. Toward Realization of a Resource Recycling Society
417-3 Incidents of non-compliance concerning marketing communications
  1. For the Materiality Targets and Progress / Implementation of Responsible Marketing and Promotion Activities
GRI 419: Socioeconomic　Compliance 2016
419-1 Non-compliance with laws and regulations in the social and economic area
  1. Governance Data
  2. For the Materiality Targets and Progress / Implementation of Responsible Marketing and Promotion Activities
ONO PHARMACEUTICAL CO.,LTD., ONO PHARMACEUTICAL CO.,LTD., system